Stock News - Tonix Pharmaceuticals Holding Corp. $TNXP
Latest Stock News for $TNXP
Tonix Pharmaceuticals Announces Phase 1 Data and Plans for Phase 2 Study of TNX-4800 for Lyme Disease Prevention
Expected Stock impact: Noticeably Positive
2026-03-31 11:08:23
Tonix Pharmaceuticals Doses First Participant in Phase 1 Study of TNX-1900 for Migraine Treatment
Expected Stock impact: Noticeably Positive
2026-03-26 11:01:28
Tonix Pharmaceuticals Dismisses EisnerAmper as Auditor, Appoints PwC
Expected Stock impact: Slightly Negative
2026-03-18 10:05:47
Tonix Pharmaceuticals Reports Strong Q4 and Full Year 2025 Results with Positive Operational Highlights
Expected Stock impact: Noticeably Positive
2026-03-13 10:06:30
